Director Julia Haller resigns from Outlook Therapeutics board, effective March 11, 2026

Outlook Therapeutics, Inc.

Dr. Julia Haller resigned as Class II director, also serving on Nominating and Corporate Governance Committee.
Board accepted resignation on March 6, 2026, effective March 11, with board size reduced to nine.
Resignation not due to any dispute with company; she cited new CEO duties at Wills Eye Hospital.
Company thanked Dr. Haller for her contributions during her tenure.

item 5.02 item 9.01

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001104659-26-026465
form_type: 8-K
ticker: OTLK
cik: 0001649989
company_name: Outlook Therapeutics, Inc.
filed_at: 2026-03-11T23:59:59+00:00
discovered_at: 2026-05-14T18:02:35.758217+00:00
generated_at: 2026-05-15T14:50:23.164767+00:00
sec_items: ["5.02", "9.01"]
event_type: leadership
sentiment: neutral
materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001104659-26-026465
json_url: https://secwatch.observer/filing/0001104659-26-026465.json
markdown_url: https://secwatch.observer/filing/0001104659-26-026465.md
text_url: https://secwatch.observer/filing/0001104659-26-026465.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1649989/000110465926026465/0001104659-26-026465-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1649989/000110465926026465/tm268371d1_8k.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Source: SEC EDGAR

accession 0001104659-26-026465

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.